This segment focuses on the research, development, and commercialization of the Nautilus Platform, a novel proteomics platform designed for single-molecule protein analysis. The platform integrates innovative technologies in biochemistry, nanotechnology, and data science to enable highly sensitive and quantitative proteome profiling. Key activities include optimizing surface chemistry for protein immobilization, developing advanced imaging techniques for protein detection, and creating sophisticated algorithms for data analysis and interpretation. The platform aims to accelerate drug discovery, biomarker identification, and personalized medicine by providing comprehensive insights into protein expression and function. Future opportunities include expanding the platform's capabilities to analyze post-translational modifications and protein-protein interactions, as well as developing customized assays for specific research and clinical applications. Partnerships with leading research institutions and pharmaceutical companies are crucial for validating the platform and driving its adoption in the market.